Frontal Fibrosing Alopecia After Antiandrogen Hormonal Therapy in a Male Patient

    January 2018 in “ Journal of the European Academy of Dermatology and Venereology ”
    Alejandro Lobato‐Berezo, Álvaro March-Rodríguez, Gustavo Deza, Marta Bertolín‐Colilla, Ramón M. Pujol
    Image of study
    TLDR A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.
    The document reports the first case of frontal fibrosing alopecia (FFA) in an 82-year-old male patient following antiandrogen hormonal therapy for prostate cancer. The patient was treated with oral bicalutamide and subcutaneous goserelin, which led to a recession of the frontotemporal hairline, hypopigmentation, atrophy in areas of alopecia, and loss of axillary and pubic hair. Clinical and histopathological features confirmed the diagnosis of FFA. The article suggests that low serum androgen levels due to the antiandrogen therapy might play a role in the induction of FFA. The authors propose that future studies should measure testosterone serum levels to assess the influence of hormonal therapies on the development of FFA. No conflicts of interest or funding sources were reported for this study.
    Discuss this study in the Community →

    Research cited in this study

    7 / 7 results

    Related Community Posts Join

    6 / 378 results

      community Testosterone and hair loss seeming irrelevance

      in Research/Science  81 upvotes 1 year ago
      The conversation is about the role of testosterone in hair loss and the effectiveness of different treatments. The conclusion is that DHT is the main culprit for hair loss, and finasteride has been proven to work long-term in maintaining and regrowing hair. Testosterone may have a minor effect, but it is not the primary cause of hair loss.

      community How essential is scalp biopsy when dealing with hair loss?

      in Treatment  6 upvotes 4 weeks ago
      The user experienced hair loss despite using Fin and Min for 12 years and switched to Dutasteride, RU58841, and Keto scalp serum, but shedding and itch persist. They are considering increasing Dutasteride to 2.5mg and questioning the necessity of a scalp biopsy, with mixed opinions on its usefulness.

      community So we’re just ok with taking a research chemical now?

      in Treatment  181 upvotes 3 years ago
      The conversation discusses the use of RU58841, a non-FDA approved research chemical for hair loss, with mixed opinions on its safety and effectiveness. Some users are willing to try it as a last resort after other treatments like Minoxidil and Finasteride failed, while others express concerns about potential long-term side effects and lack of official research.

      community I tried salt water to stop the DHT itch

      in Treatment  60 upvotes 1 year ago
      Treating the itch associated with male pattern baldness, which is believed to be caused by DHT. Potential treatments discussed include salt water, finasteride, ketoconazole, and RU58841.

    Similar Research

    5 / 1000+ results